Nav: Home

Researchers discover a genetic defect linked to pediatric liver disease

February 21, 2019

AURORA, Colo. (Feb. 21, 2019) - Researchers from the University of Colorado Anschutz Medical Campus, in collaboration with several other institutions, have discovered a genetic defect linked to Biliary atresia (BA), the most common pediatric cause of end-stage liver disease, and the leading indication for liver transplantation in children.

Their findings were published January in the journal Hepatology.

"We don't know the cause of Biliary atresia, which interferes with our ability to treat affected children," said study co-author Ronald Sokol, MD, a pediatric gastroenterologist and hepatologist at Children's Hospital Colorado and Director of the Colorado Clinical and Translational Sciences Institute (CCTSI) at CU Anschutz.

By identifying a genetic mutation linked to the disease, Sokol, along with researchers from Emory University, University of Utah, Children's Hospital of Philadelphia, Washington University at St. Louis, and others, may finally determine the cause of this devastating condition. The group used next-generation gene sequencing to discover that a genetic defect of the gene PKD1L1 was linked to BA in a subset of patients.

Some children with BA also have splenic abnormalities and cardiac malformations called biliary atresia splenic malformation syndrome or BASM. Researchers hypothesized that the genetic factors causing an asymmetric position of organs in the body could also cause the development of BA in BASM patients, and that the genes involved could be discovered using whole exome sequencing.

So they sequenced DNA specimens from 67 subjects with BASM, including 58 patient-parent trios. Researchers looked at 2,016 genes - a subset of the full genome - that were associated with proteins that were candidates to cause a disease like BA. The study found five patients who had two copies of mutations in the gene PKD1L1 and three additional patients who had one mutation in the gene.

"The importance of this is that researchers have never identified a gene, when mutated, that causes BA," Sokol said. "This is the first time it has been found."

The CCTSI's Pediatric Clinical and Translational Research Center played a key role in the study. The patients who were participants came from a liver disease research network, which Dr. Sokol chairs, the Childhood Liver Disease Research Network (ChiLDReN). This network has been funded by the NIH for 15 years and includes 14 centers across the nation, Canada and the UK.

The gene that was identified may be the first of other genes to be found to be linked with BASM or BA. Understanding what causes BA is a breakthrough that could lead to new therapeutic approaches that would ultimately avoid liver transplantation.

In the first analysis of the data, researchers looked at more than 2,000 genes. Now that they have the data from the whole exome sequencing, researchers can go back and analyze the other 18,000 genes for other genetic causes of BA.

"What we learn about what causes the disease could translate into new therapeutic targets and strategies," Sokol said.
-end-


University of Colorado Anschutz Medical Campus

Related Liver Transplantation Articles:

The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer
Recent research results from the European consortium IT-Liver provide a better understanding of the role of the TGF-beta cytokine in liver cancer.
Critically ill children can still undergo liver transplantation and survive
Advancements in critical care make it possible for even the sickest children to successfully undergo liver transplantation.
New approach to liver transplantation: Using a damaged liver to replace a dying liver
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.
Brazil faces major challenges in liver transplantation
A recent analysis indicates that more than 1,700 liver transplantations are performed annually in Brazil.
Damage to tiny liver protein function leads to heart disease, fatty liver
A UCF College of Medicine researcher has identified for the first time a tiny liver protein that when disrupted can lead to the nation's top killer -- cardiovascular disease -- as well as fatty liver disease, a precursor to cancer.
Transplanted liver cells protect against liver failure after massive hepatectomy surgery
Because liver failure often occurs after an extensive hepatectomy, researchers using animal models investigated safer ways to transplant liver cells post-extensive hepatectomy found that rather than transplanting cells into the liver portal vein, transplantation into an extra-hepatic site, such as the intra-mesentery, a fold of membranous tissue on the posterior wall of the abdominal cavity attached to the intestinal tract, can help protect against post-operative liver failure and aid in survival of the remaining liver.
Study's findings could help expand the donor pool for liver transplantation
Organ donation after circulatory death, in which transplant organs are taken from donors after ay period of no blood circulation or oxygenation, is often considered inferior to donation after brain death, in which circulation and oxygenation are maintained until organs are removed for transplantation
Cell transplantation procedure may one day replace liver transplants
In an effort to find therapeutic alternatives to whole liver transplantation and improve the outcomes of hepatocyte transplantation, researchers tested the efficacy and feasibility of transplanting multi-layered sheets of hepatocytes and fibroblasts into the subcutaneous cavity of laboratory rats modeled with end stage liver failure.
Live donor liver transplantation found safe and effective for acute liver failure
When patients develop acute liver failure, severe complications arise rapidly after the first signs of liver disease, and patients' health can deteriorate rapidly.
Interferon-free combination therapy prevents recurrence of HCV after liver transplantation
A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus infection in two-thirds of patients who undergo liver transplantation, with positive consequences on their short- and long-term prognoses, according to two new studies published in Gastroenterology, the official journal of the American Gastroenterological Association.

Related Liver Transplantation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".